Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-13 7:29 pm | Panbela Therapeutics Inc. | PBLA | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 72,874 | $0.71 | $51,741 | 397,954 (Indirect) | View |
| 2023-01-30 Purchase | 2023-02-01 4:37 pm | Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO | 4,444 | $0 | $0 | 16,756 (Direct) | View |
| 2023-01-30 Purchase | 2023-02-01 4:36 pm | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 4,444 | $0 | $0 | 26,768 (Direct) | View |
| 2022-10-04 Purchase | 2022-10-06 6:14 pm | Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner | 165,000 | $0 | $0 | 833,387 (Indirect Direct) | View |
| 2022-10-04 Purchase | 2022-10-06 5:26 pm | Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner | 200,000 | $0 | $0 | 879,273 (Indirect Direct) | View |
| 2022-10-04 Purchase | 2022-10-06 5:24 pm | Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director | 33,000 | $0 | $0 | 416,576 (Indirect Direct) | View |
| 2020-09-10 Purchase | 2020-09-14 5:52 pm | Sun BioPharma Inc. | SNBP | Simpson Jennifer K. President and CEO | 1,000 | $2.7371 | $2,737 | 3,424 (Direct) | View |
| 2020-09-04 Purchase | 2020-09-09 9:28 pm | Sun BioPharma Inc. | SNBP | Schaffer Paul W. Director | 25,000 | $2.5093 | $62,732 | 190,085 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-29 7:38 pm | 2024-10-22 2025-04-22 | Panbela Therapeutics Inc. | PBLA | Nant Capital LLC SOON-SHIONG PATRICK 10% Owner | 0 | $0 | 7,702,702 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 4:26 pm | N/A 2034-10-01 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 25,480 | $0 | 25,480 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 4:25 pm | N/A 2034-10-01 | Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO | 72,800 | $0 | 72,800 (Direct) | View |
Ownership | 2023-11-13 7:27 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 0 | $0 | 360,464 (Indirect) | View |
| 2023-09-12 Gift | 2023-09-14 4:06 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director | 275 | $0 | 27 (Indirect) | View |
| 2023-03-27 Option Award | 2023-03-29 4:26 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO | 99,383 | $0 | 99,383 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:25 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 34,369 | $0 | 34,369 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:24 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner | 8,333 | $0 | 8,333 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:22 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Donovan Daniel Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:22 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:21 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:19 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 4:18 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner | 8,333 | $0 | 8,333 (Direct) | View |
Ownership | 2022-06-27 08:44 am | N/A N/A | Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director | 0 | $0 | 685,797 (Direct) | View |
Ownership | 2022-06-24 4:46 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | Donovan Daniel Director | 0 | $0 | 375,036 (Direct) | View |
| 2021-09-13 Option Award | 2021-09-15 6:00 pm | N/A 2031-09-13 | Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO | 19,125 | $0 | 19,125 (Direct) | View |
| 2021-09-13 Option Award | 2021-09-15 5:59 pm | N/A 2031-09-13 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 12,135 | $0 | 12,135 (Direct) | View |
| 2021-01-06 Gift | 2021-06-11 10:34 am | N/A N/A | Panbela Therapeutics Inc. | PBLA | Gagnon Suzanne Director | 11,426 | $0 | 46,284 (Indirect) | View |
| 2021-05-25 Option Award | 2021-05-27 8:54 pm | N/A 2031-05-25 | Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director | 16,684 | $0 | 21,983 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 8:52 pm | N/A 2031-05-25 | Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner | 16,684 | $0 | 391,641 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 8:51 pm | N/A 2031-05-25 | Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director | 16,684 | $0 | 22,559 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 8:49 pm | N/A 2031-05-25 | Panbela Therapeutics Inc. | PBLA | Schaffer Paul W. Director | 16,684 | $0 | 209,704 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 8:48 pm | N/A 2031-05-25 | Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner | 16,684 | $0 | 433,755 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 09:33 am | N/A 2031-03-30 | Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO | 170,000 | $0 | 170,000 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 09:33 am | N/A 2031-03-30 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 09:31 am | N/A 2031-03-30 | Panbela Therapeutics Inc. | PBLA | Gagnon Suzanne Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 09:31 am | N/A 2031-03-30 | Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Executive Chairman 10% Owner | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 4:15 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | Schaffer Paul W. Director | 2,875 | $0 | 192,960 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 4:13 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director | 2,875 | $0 | 5,875 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 4:12 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner | 2,875 | $0 | 374,957 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 4:11 pm | N/A N/A | Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director | 2,875 | $0 | 5,299 (Direct) | View |